丹麦西部2016-2022年重度主动脉瓣狭窄经导管或外科Perimount瓣置换全国回顾性研究
该全国回顾性观察研究纳入2016年1月至2022年4月丹麦西部所有因重度主动脉瓣狭窄行择期单纯经股动脉TAVI或SAVR的患者,经倾向评分匹配后比较长期死亡与临床结局。匹配后TAVI组5年全因死亡率为29.8%,SAVR组为16.9%(P=0.019);5年全部卒中或短暂性脑缺血发作风险TAVI组为15.1%,SAVR组为11.0%(P=0.047)。作者认为选择瓣膜置换方式时应评估所有患者因素,SAVR对NYHA I/II级、≥75岁、左心室射血分数≥50%或预期寿命较长者是极佳选择。
要点
- 匹配后5年全因死亡率TAVI组29.8% vs SAVR组16.9%(P=0.019)。
- 匹配后5年全部卒中或TIA风险TAVI组15.1% vs SAVR组11.0%(P=0.047)。
- 作者认为SAVR对NYHA I/II级、≥75岁、LVEF≥50%或预期寿命较长者是极佳选择。
核心结论
- 本研究强调选择主动脉瓣置换方式时应评估所有患者因素。
- 外科主动脉瓣置换是极佳选择,尤其对NYHA I/II级、≥75岁、左心室射血分数≥50%或预期寿命较长的患者。
研究设计与样本
- 观察性研究,纳入2016年1月至2022年4月丹麦西部所有因重度主动脉瓣狭窄行择期单纯经股动脉TAVI或SAVR的患者。
- 患者人群与临床数据分别来自西部丹麦心脏登记处和丹麦国家患者登记处,并生成倾向评分匹配人群。
- 共识别2269例TAVI患者和1094例SAVR患者;倾向评分匹配人群为468例TAVI患者(平均[SD]年龄75.0[5.3]岁)和468例SAVR患者(平均[SD]年龄75.1[4.6]岁)。
- 结局依据Valve Academic Research Consortium-3标准评估。
主要发现
- 匹配后5年全因死亡率的Kaplan-Meier估计值TAVI组为29.8%,SAVR组为16.9%(P=0.019)。
- 匹配后5年全部卒中或短暂性脑缺血发作风险TAVI组为15.1%,SAVR组为11.0%(P=0.047)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The healthcare registries in Denmark present a unique opportunity to gain novel insights into the outcomes associated with both transcatheter and surgical approaches to aortic valve replacement. Our objective is to enhance shared decision-making by comparing long-term mortality and clinical outcomes between treatments. METHODS: This observational study included all patients with severe aortic stenosis undergoing elective isolated transfemoral transcatheter aortic valve implantation (TAVI) or surgical aortic valve replacement (SAVR) in Western Denmark between January 2016 and April 2022. Patient population and clinical data were identified from the Western Danish Heart Registry and the National Danish Patient Registry, respectively. A propensity score-matched population was generated. Outcomes were investigated according to Valve Academic Research Consortium-3. RESULTS: A total of 2269 TAVI patients and 1094 SAVR patients where identified. The propensity score-matched population consisted of 468 TAVI patients (mean[SD]age, 75.0[5.3] years) and 468 SAVR patients (mean[SD] age, 75.1[4.6]years). The Kaplan-Meier estimate for the 5-year all-cause mortality was 29.8% in the TAVI group and 16.9% for in the SAVR group (P = 0.019). The risk of all stroke or transient ischaemic attack after five year was 15.1% in the TAVI group and 11.0% in the SAVR group (P = 0.047). CONCLUSIONS: This study underscores the importance of evaluating all patient factors when choosing an aortic valve replacement method. Surgical aortic valve replacement was an excellent choice, especially for patients with New York Heart Association class I/II, ≥75 age, left ventricular ejection fraction ≥50%, or longer life expectancy.
引用
- Krasniqi L, Brandes A, Mortensen PE, et al. Severe aortic stenosis treated with transcatheter aortic valve implantation or surgical aortic valve replacement with Perimount in Western Denmark 2016-2022: a nationwide retrospective study. Interdiscip Cardiovasc Thorac Surg. 2024. PMID: 38944031. doi:10.1093/icvts/ivae122
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。